Catalyst Event
3SBio Inc (1530) · Earnings Release
From Akros SCHK HK-US Biotech Index (ASHUBIO)
3/30/2026, 12:00:00 AM
Board meeting to be held on March 30, 2026, to approve and announce the annual results for the year ended December 31, 2025. High importance estimated as annual results typically result in ≥10% price impact, scheduled.
Korean Translation
2026년 3월 30일, 2025년 12월 31일 마감 연간 실적 승인 및 발표림 위한 이사회 개최. 연간 실적 발표는 통상 10% 이상의 주가 변동을 동반하므로 중요도림 'High'로 산정하여 예정됨.
Related Recent Events
CSPC Pharmaceutical Group Ltd (1093) · Other
Final dividend of HKD 0.15 per share for FY2025 (total HKD 0.29, +11.5% YoY) with ex-dividend date June 24, 2026; low importance as dividend increases typically result in minor positive price adjustments scheduled.
6/24/2026, 12:00:00 AM
Pfizer Inc (PFE) · Earnings Release
High importance is estimated due to the potential for significant price volatility for Pfizer's Q1 2026 earnings release and conference call, scheduled.
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release and conference call scheduled; typically results in moderate price movement.
4/30/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Q1 2026 earnings release and conference call scheduled.
4/30/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Q1 2026 earnings release and conference call for 2026-04-30, estimated to have a low impact of ~1-2% based on historical trends, scheduled.
4/30/2026, 12:00:00 AM
Regeneron Pharmaceuticals Inc (REGN) · Earnings Release
Regeneron is scheduled to report its first quarter 2026 financial and operating results on 2026-04-29. Importance is Medium as earnings typically drive significant price movement, scheduled.
4/29/2026, 12:00:00 AM